Raised to take university technology to market


Active licence agreements


Gross product sales of licensed
UQ technologies


In revenue returned to UQ since 2002


Companies created from our intellectual property portfolio


Granted US patents

Impact highlights

Our commercialisation impact makes The University of Queensland Australia’s top university for licence income and value of equity held in spin-out companies.*

*National Survey of Research Commercialisation, Department of Industry, Innovation and Science, 2021
gardasil cervica cancer vaccine

Gardasil®: A global solution to eradicating cervical cancer

The Gardasil® cervical cancer vaccine has led to a decrease of approximately 90 per cent in the prevalence of human papillomavirus (HPV), the major cause of cervical cancer.

UQ technology with the power to revolutionise global vaccine delivery

Vaxxas Pty Ltd is set to revolutionise vaccine delivery through its innovative High-Density Microarray Patch (HD-MAP).

Encapsulated probiotic drink a world first

The world’s first encapsulated probiotic drink uses patented micro-shield technology to deliver targeted in-gut release of effective probiotics.

UQ's ResAppDx smartphone app is being used to diagnose respiratory diseases in a range of settings.

A smartphone app helping doctors and patients breathe easier

Just one cough and a simple and inexpensive new smartphone technology can instantly and accurately identify respiratory diseases.

Bringing the benefits of positive parenting to the world

The Triple P-Positive Parenting Program is changing the lives of millions of families around the world and helping to build stronger, more resilient communities.

Professor Stuart Crozier with MRI scan technology commercialised by UniQuest.

MRI scan technology is savings lives around the world

UQ’s innovative technology, which is used in most of the world’s MRI machines, has helped more than 8 billion people across the globe.

Contact our team

UniQuest has access to over 7000+ UQ researchers with research at or above world standard across 30 research strength areas.

Contact us today